TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Metastatic Cancer Drugs Market – By Cancer Type
1.3.2 Middle East and Africa Metastatic Cancer Drugs Market – By Route of Administration
1.3.3 Middle East and Africa Metastatic Cancer Drugs Market – By Drug Class
1.3.4 Middle East and Africa Metastatic Cancer Drugs Market – By Product
1.3.5 Middle East and Africa Metastatic Cancer Drugs Market – By End User
1.3.6 Middle East and Africa Metastatic Cancer Drugs Market – By Country
2. Middle East and Africa Metastatic Cancer Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Metastatic Cancer Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa– PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Metastatic Cancer Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Metastatic Cancer
5.1.2 Government Initiatives to Support Developments in Cancer Treatment
5.2 Market Restraints
5.2.1 High Cost of Oncology Drugs
5.3 Market Opportunities
5.3.1 Investments in Artificial Intelligence for Oncology Drug Development
5.4 Future Trends
5.4.1 Increase in Launch of Metastatic Cancer Drugs
5.5 Impact analysis
6. Middle East and Africa Metastatic Cancer Drugs Market –Country Analysis
6.1 Middle East and Africa Metastatic Cancer Drugs Market Revenue Forecast and Analysis
6.1.1 Middle East and Africa : Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn)
7. Middle East and Africa Metastatic Cancer Drug Market Analysis – By Cancer Type
7.1 Overview
7.2 Middle East and Africa Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)
7.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
7.3 Breast Cancer
7.3.1 Overview
7.3.2 Breast Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lung Cancer
7.4.1 Overview
7.4.2 Lung Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver Cancer
7.5.1 Overview
7.5.2 Liver Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Hematological Cancer
7.6.1 Overview
7.6.2 Haematological Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Brain Cancer
7.7.1 Overview
7.7.2 Brain Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Prostate Cancer
7.8.1 Overview
7.8.2 Prostate Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Pancreatic Cancer
7.9.1 Overview
7.9.2 Pancreatic Cancer: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Metastatic Cancer Drug Market – By Route of Administration
8.1 Overview
8.2 Middle East and Africa Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)
8.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
8.3 Intravenous
8.3.1 Overview
8.3.2 Intravenous: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Intramuscular
8.4.1 Overview
8.4.2 Intramuscular: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East and Africa Metastatic Cancer Drug Market – By Drug Class
9.1 Overview
9.2 Middle East and Africa Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)
9.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
9.3 HER2 Inhibitors
9.3.1 Overview
9.3.2 HER2 Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Immune Checkpoints Inhibitors
9.4.1 Overview
9.4.2 Immune Checkpoints Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.5 PARP Inhibitors
9.5.1 Overview
9.5.2 PARP Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Kinase Inhibitors
9.6.1 Overview
9.6.2 Kinase Inhibitors: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East and Africa Metastatic Cancer Drug Market – By Product
10.1 Overview
10.2 Middle East and Africa Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)
10.2.1 Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.3 Branded
10.3.1 Overview
10.3.2 Branded: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Generics and Biosimilars
10.4.1 Overview
10.4.2 Generics and Biosimilars: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East and Africa Metastatic Cancer Drug Market – By End User
11.1 Overview
11.2 Middle East and Africa Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)
11.2.1 Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
11.3 Hospital
11.3.1 Overview
11.3.2 Hospitals: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Specialty Clinic
11.4.1 Overview
11.4.2 Specialty Clinics: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Middle East and Africa Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
12. Middle East and Africa Metastatic Cancer Drugs Market – Regional Analysis
12.1 Middle East and Africa: Metastatic Cancer Drugs Market
12.1.1 Overview
12.1.2 Middle East & Africa: Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)
12.1.2.1 Saudi Arabia: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Saudi Arabia: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.3 Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.4 Saudi Arabia Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.5 Saudi Arabia Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.6 Saudi Arabia: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.2 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 UAE: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.3 UAE Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.4 UAE Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.5 UAE Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.6 UAE: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.3 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 South Africa: Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.3 South Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.4 South Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.5 South Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.6 South Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
12.1.2.4 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Rest of Middle East and Africa: Metastatic Cancer Drug Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.3 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.4 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.5 Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.6 Rest of Middle East & Africa: Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)
13. Middle East and Africa Metastatic Cancer Drug Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market, 2021-2028
13.3 Inorganic Developments
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Amgen Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. HOFFMANN-LA ROCHE LTD.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Astrazeneca
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MERCK KGaA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Johnson and Johnson Services, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES.
Table 1. Middle East and Africa: Middle East and Africa Metastatic Cancer Drug Market - Revenue and Forecasts to 2028, (US$ Mn).
Table 2. Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5. Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. Saudi Arabia Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 10. Saudi Arabia Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. Saudi Arabia Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. UAE Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. South Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 18. South Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. South Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 20. South Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 21. South Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of Middle East & Africa Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Middle East & Africa Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 27. Recent Inorganic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market
Table 28. Recent Organic Growth Strategies in the Middle East and Africa Metastatic Cancer Drug Market
Table 29. Glossary of Terms, Middle East and Africa Metastatic Cancer Drugs Market